Allan D Herrmann

Array ( [id] => 3506810 [patent_doc_number] => 05562909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Phosphazene polyelectrolytes as immunoadjuvants' [patent_app_type] => 1 [patent_app_number] => 8/090841 [patent_app_country] => US [patent_app_date] => 1993-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6542 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/562/05562909.pdf [firstpage_image] =>[orig_patent_app_number] => 090841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3557279 [patent_doc_number] => 05502037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Pro-cytotoxic drug conjugates for anticancer therapy' [patent_app_type] => 1 [patent_app_number] => 8/088646 [patent_app_country] => US [patent_app_date] => 1993-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5608 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/502/05502037.pdf [firstpage_image] =>[orig_patent_app_number] => 088646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3425088 [patent_doc_number] => 05462735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-31 [patent_title] => 'Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide' [patent_app_type] => 1 [patent_app_number] => 8/075064 [patent_app_country] => US [patent_app_date] => 1993-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4081 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/462/05462735.pdf [firstpage_image] =>[orig_patent_app_number] => 075064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2993162 [patent_doc_number] => 05358710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Method for the suppression of an immune response' [patent_app_type] => 1 [patent_app_number] => 8/066314 [patent_app_country] => US [patent_app_date] => 1993-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5826 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/358/05358710.pdf [firstpage_image] =>[orig_patent_app_number] => 066314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3054680 [patent_doc_number] => 05350575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-27 [patent_title] => 'IBDV VP2 epitope recognized by virus neutralizing and protective monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/052289 [patent_app_country] => US [patent_app_date] => 1993-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4678 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/350/05350575.pdf [firstpage_image] =>[orig_patent_app_number] => 052289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3096776 [patent_doc_number] => 05292868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-08 [patent_title] => 'Chelating agents for attaching metal ions to proteins' [patent_app_type] => 1 [patent_app_number] => 8/044875 [patent_app_country] => US [patent_app_date] => 1993-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5976 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/292/05292868.pdf [firstpage_image] =>[orig_patent_app_number] => 044875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3020347 [patent_doc_number] => 05302703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-12 [patent_title] => 'Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels' [patent_app_type] => 1 [patent_app_number] => 8/032598 [patent_app_country] => US [patent_app_date] => 1993-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4322 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/302/05302703.pdf [firstpage_image] =>[orig_patent_app_number] => 032598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3028707 [patent_doc_number] => 05342771 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-30 [patent_title] => 'Functionalized imidazolinone haptens and protein conjugates thereof useful in assays for the detection of imidazolinone herbicides' [patent_app_type] => 1 [patent_app_number] => 8/023231 [patent_app_country] => US [patent_app_date] => 1993-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3802 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/342/05342771.pdf [firstpage_image] =>[orig_patent_app_number] => 023231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3521073 [patent_doc_number] => 05527527 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Transferrin receptor specific antibody-neuropharmaceutical agent conjugates' [patent_app_type] => 1 [patent_app_number] => 8/004986 [patent_app_country] => US [patent_app_date] => 1993-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 13100 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527527.pdf [firstpage_image] =>[orig_patent_app_number] => 004986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3481213 [patent_doc_number] => 05399710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-21 [patent_title] => 'Protein labeling reagents' [patent_app_type] => 1 [patent_app_number] => 7/994939 [patent_app_country] => US [patent_app_date] => 1992-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6079 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/399/05399710.pdf [firstpage_image] =>[orig_patent_app_number] => 994939 [rel_patent_id] =>[rel_patent_doc_number] =>)